Pacer Advisors Inc. increased its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 41.6% during the 1st quarter, Holdings Channel reports. The fund owned 448,722 shares of the technology company’s stock after purchasing an additional 131,913 shares during the quarter. Pacer Advisors Inc.’s holdings in Amdocs were worth $29,284,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. TABR Capital Management LLC purchased a new position in shares of Amdocs in the 4th quarter valued at about $2,398,000. BNP Paribas Financial Markets raised its holdings in Amdocs by 85.4% in the fourth quarter. BNP Paribas Financial Markets now owns 201,982 shares of the technology company’s stock valued at $16,262,000 after acquiring an additional 93,036 shares in the last quarter. Aberdeen Group plc raised its holdings in Amdocs by 13.2% in the fourth quarter. Aberdeen Group plc now owns 263,287 shares of the technology company’s stock valued at $21,197,000 after acquiring an additional 30,723 shares in the last quarter. Arbejdsmarkedets Tillaegspension lifted its stake in Amdocs by 17.5% in the first quarter. Arbejdsmarkedets Tillaegspension now owns 354,383 shares of the technology company’s stock worth $23,127,000 after acquiring an additional 52,906 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its stake in Amdocs by 429.6% in the first quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company’s stock worth $19,043,000 after acquiring an additional 236,700 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on the stock. Cfra downgraded shares of Amdocs to a “sell” rating in a research report on Thursday, May 14th. KeyCorp initiated coverage on shares of Amdocs in a research report on Monday, June 29th. They set a “sector weight” rating for the company. Stifel Nicolaus lowered their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Finally, Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research note on Sunday, July 5th. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $86.67.
Amdocs Stock Performance
Shares of Amdocs stock opened at $55.37 on Tuesday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 52 week low of $49.74 and a 52 week high of $90.29. The firm’s 50 day moving average is $54.77 and its two-hundred day moving average is $63.90. The firm has a market capitalization of $5.98 billion, a P/E ratio of 11.07, a P/E/G ratio of 0.97 and a beta of 0.41.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the firm earned $1.78 EPS. The company’s revenue was up 3.9% compared to the same quarter last year. Research analysts forecast that Amdocs Limited will post 6.56 EPS for the current fiscal year.
Amdocs Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were given a $0.569 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a yield of 4.1%. Amdocs’s payout ratio is 45.40%.
Amdocs Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
See Also
- Five stocks we like better than Amdocs
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
